DGX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
3.0B
+5.1%
2.9B
+3.2%
2.8B
-0.4%
2.8B
+2.0%
2.8B
Cost of Revenue
2.0B
+3.2%
2.0B
+3.0%
1.9B
+1.6%
1.9B
+2.7%
1.8B
Gross Profit
1.0B
+9.0%
942.0M
+3.5%
910.0M
-4.1%
949.0M
+0.6%
943.0M
Operating Expenses
568.0M
+5.0%
541.0M
+0.0%
541.0M
+0.2%
540.0M
+6.9%
505.0M
R&D
0
0
0
0
0
SG&A
529.0M
+5.0%
504.0M
+0.0%
504.0M
+0.6%
501.0M
+3.1%
486.0M
Operating Income
459.0M
+14.5%
401.0M
+8.7%
369.0M
-9.8%
409.0M
-6.6%
438.0M
EBITDA
605.0M
+10.4%
548.0M
+6.6%
514.0M
-6.7%
551.0M
-5.2%
581.0M
Net Income
334.0M
+26.5%
264.0M
+3.1%
256.0M
-1.2%
259.0M
-12.5%
296.0M
EPS (Basic)
$2.88
+26.9%
$2.27
+2.3%
$2.22
+1.8%
$2.18
-13.1%
$2.51
EPS (Diluted)
$2.84
+26.8%
$2.24
+3.2%
$2.17
+0.5%
$2.16
-12.6%
$2.47
Shares (Diluted)
112.0M
+0.0%
112.0M
-0.9%
113.0M
+0.0%
113.0M
+0.0%
113.0M
Quest Diagnostics (DGX) โ€” Financials